Ocio E, Mateos M-V, Magen H, Gatt M, Sebag M, Kim K, Min C-K, Yoon S-S, Chu M, Rodríguez-Otero P, Avivi I, Quijano Cardé N, Krevvata M, Henninger T, Thakkar P, Festa M, Huang L, Zhou J, Takamoto M, Pei L, Lu J, Maffucci C, Scott E, Oriol A, Morillo D, Cohen Y. P38 | SAFETY AND EFFICACY OF TALQUETAMAB + TECLISTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM PHASE 1b OF RedirecTT-1: RESULTS WITH AN EXTENDED MEDIAN FOLLOW-UP OF 3 YEARS. haematol [Internet]. 2026Apr.15 [cited 2026Apr.21];111(s2). Available from: https://haematologica.org/article/view/haematol.2026.s2.14054